2019 | A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy
| JOURNAL OF CLINICAL MEDICINE |
2019 | A Lesion-Based Convolutional Neural Network Improves Endoscopic Detection and Depth Prediction of Early Gastric Cancer
| Journal of Clinical Medicine |
2009 | A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status | ONCOLOGY |
2010 | A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer. | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
2006 | A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer | ONCOLOGY |
2008 | A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2007 | A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
| BRITISH JOURNAL OF CANCER |
2004 | A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
| ANNALS OF ONCOLOGY |
2007 | A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2013 | A Pilot Study for Preoperative Concurrent Chemoradiotherapy with S-1 and Cisplatin for Locally Advanced Gastric Cancer | HEPATO-GASTROENTEROLOGY |
2012 | A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer | INVESTIGATIONAL NEW DRUGS |
2011 | A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis | ONCOLOGY |
2011 | A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy
| CANCER |
2017 | Additive endoscopic resection may be sufficient for patients with a positive lateral margin after endoscopic resection of early gastric cancer | GASTROINTESTINAL ENDOSCOPY |
2012 | Additive lymph node dissection may be necessary in minute submucosal cancer of the stomach after endoscopic resection | ANNALS OF SURGICAL ONCOLOGY |
2004 | Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model
| WORLD JOURNAL OF GASTROENTEROLOGY |
2001 | Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute. | CANCER |
2012 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial | LANCET |
2014 | Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. | LANCET ONCOLOGY |
2011 | Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis.
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
1998 | Alpha-fetoprotein-producing gastric cancer | ONCOLOGY REPORTS |
2020 | Altered systematic glucose utilization after gastrectomy: correlation with weight loss | SURGERY FOR OBESITY AND RELATED DISEASES |
2012 | AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer.
| CANCER RESEARCH |
1998 | An unusual case of gastric carcinoma with synchronous non-Hodgkin's lymphoma
| YONSEI MEDICAL JOURNAL |
2010 | Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea
| WORLD JOURNAL OF GASTROENTEROLOGY |
2014 | Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer | PATHOLOGY |
2008 | Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
| MOLECULAR CANCER RESEARCH |
2016 | Are new criteria for mixed histology necessary for endoscopic resection in early gastric cancer? | PATHOLOGY RESEARCH AND PRACTICE |
2016 | Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy. | ONCOLOGY |
2010 | Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. | ONCOLOGY REPORTS |
2007 | ATP-Based Chemotherapy Response Assay in Patients with Unresectable Gastric Cancer | ONCOLOGY |
2002 | Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment. | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
2014 | Can we apply the same indication of endoscopic submucosal dissection for primary gastric cancer to remnant gastric cancer? | GASTRIC CANCER |
2007 | Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single korean institute | ANNALS OF SURGICAL ONCOLOGY |
2010 | Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression | CANCER SCIENCE |
2020 | Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer
| MOLECULAR THERAPY-ONCOLYTICS |
2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | CANCER LETTERS |
2013 | Clinical implication of endoscopic gross appearance in early gastric cancer: revisited | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
2010 | Clinical implication of positive oral contrast computed tomography for the evaluation of postoperative leakage after gastrectomy for gastric cancer | JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY |
2017 | Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project | CLINICAL CANCER RESEARCH |
2000 | Clinicopathologic characteristics of early gastric cancer in Korea
| Yonsei Medical Journal |
2021 | Clinicopathologic Features of Submucosal Papillary Gastric Cancer Differ from Those of Other Differentiated-Type Histologies
| GUT AND LIVER |
2009 | Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients | JOURNAL OF SURGICAL ONCOLOGY |
2010 | Clinicopathological features and prognostic factors of proximal gastric carcinoma in a population with high Helicobacter pylori prevalence: a single-center, large-volume study in Korea | ANNALS OF SURGICAL ONCOLOGY |
2015 | Clinicopathological features and prognostic significance of HER2 expression in gastric cancer | ONCOLOGY |
2018 | Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
1997 | Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate | CANCER LETTERS |
2018 | Comparison of long-term clinical outcomes between endoscopic and surgical resection for early-stage adenocarcinoma of the esophagogastric junction | SURGICAL ONCOLOGY-OXFORD |
2017 | Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
| ONCOTARGET |
2016 | Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
| ONCOTARGET |
2009 | Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer | INTERNATIONAL JOURNAL OF ONCOLOGY |
2005 | Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors | ONCOGENE |
2010 | CT colonography for postoperative surveillance after curative gastrectomy in patients with gastric cancer | JOURNAL OF SURGICAL ONCOLOGY |
2016 | Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy | ANNALS OF SURGERY |
2021 | Daytime Glycemic Variability and Frailty in Older Patients with Diabetes: a Pilot Study Using Continuous Glucose Monitoring
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2013 | Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation | RADIOTHERAPY AND ONCOLOGY |
2021 | Detection of asymptomatic recurrence improves survival of gastric cancer patients
| CANCER MEDICINE |
2022 | Development and validation of a prognostic and predictive 32-gene signature for gastric cancer
| NATURE COMMUNICATIONS |
2016 | Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
| CLINICAL CANCER RESEARCH |
2004 | Differences in genetic expression profiles between young-age and old-age gastric adenocarcinoma using cDNA microarray for endocrine disruptor study | ONCOLOGY REPORTS |